The incidence and economic costs of cancer, motor vehicle injuries, coronary heart disease, and stroke: a comparative analysis.

Abstract

The economic impact of disease and injury has most often been calculated by examining the costs associated with the prevalence of the impairments in the reference year. An alternative accounting approach is to assign all disease costs to the year of incidence, an approach which entails present-valuing to the year of incidence both health care expenditures and lost productivity. The incidence approach is the more appropriate for gauging the economic gains achievable through prevention, immediate rehabilitation, and arresting progression. Incidence-based costs have been estimated for the United States in 1975 for cancer, coronary heart disease, motor vehicle injuries, and stroke. A noteworthy finding is the relative economic importance of motor vehicle injuries, which frequently have been overlooked in the ordering of public health expenditure priorities. After cancer, which generated approximately $23.1 billion in present-valued costs in 1975

Gene expression profiling and breast cancer care: What are the potential benefits and policy implications?

“…We thus undertook an attributable cost analysis using managed care reimbursement data, 21 and statistical methods that account for censored data. 22,23 This approach estimated chemotherapy attributable costs as the difference between the cancer attributable costs of women with chemotherapy and women without chemotherapy. Briefly, we identified cases from a linked database of claims records from a health plan covering persons under age 65.…”

Cost of Stroke in Australia From a Societal Perspective

“…9,12 A number of cost-of-illness (COI) studies for stroke have been conducted by means of an incidence-based approach. 4,7,10,[13][14][15] The incidence-based approach estimates the present value of the lifetime costs for all new (incident) cases occurring during a given reference year, even though many costs will actually be incurred during future years. This is the method of choice if the consequences of preventative and treatment strategies are to be appreciated in terms of their effects on lifetime costs and options for change evaluated in terms of their economic efficiency.…”

Assessing the economic burden of injuries due to accidents: methodological problems illustrated with some examples from the literature

“…Policy Analysis Inc. [17] examined the costs of breast cancer, diabetes mellitus, rheumatoid arhtritis, stroke and acute lymphocytic leukemia, while Hartunian, Smart and Thompson [16,18] estimated the costs of cancer, coronary heart disease, stroke and motor vehicle injuries for the United States in 1975. Table 4 presents the estimated direct and indirect costs of motor vehicle injuries in the U.S.A. as a function of the Maximum Abbreviated Injury Severity Score (MAISS).…”